Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors? Mooney SJ, Rundle AG. Cancer Epidemiol Biomarkers Prev 2026;35:138-143.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mooney SJ, Rundle AG. Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors? Cancer Epidemiol Biomarkers Prev 2026;35:138-143.
PMID: 41191412